http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011033435-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b1549c5b13fe330cb836ac2e3a1fc96
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2531-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
filingDate 2010-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c98b617b1c9ce0569f6482854015a5ab
publicationDate 2011-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2011033435-A1
titleOfInvention Composition of activated CD4 cells
abstract The composition of activated CD4 cells is derived from a healthy human donor. The composition from the healthy human donor is suspended in an infusion media and packaged in a vehicle for administration to a subject to treat disease.
priorityDate 2003-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6905874-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5806529-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6534055-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002115214-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004228848-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6352694-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002127208-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6905680-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749

Total number of triples: 40.